HAEGARDA® [C1 Esterase Inhibitor Subcutaneous (Human)]
- Home
- HAEGARDA® [C1 Esterase Inhibitor Subcutaneous (Human)]
Full Prescribing Information: bit.ly/3sYZaL9
Important Safety Information: bit.ly/3sYL0d2 We do ask that all users comply with Facebook’s Terms of Use.
Address
Website
Alerts
Be the first to know and let us send you an email when HAEGARDA® [C1 Esterase Inhibitor Subcutaneous (Human)] posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Shortcuts
- Address
- Alerts
- Contact The Practice
- Claim ownership or report listing
-
Want your practice to be the top-listed Clinic?
Thank you for visiting HAEGARDA®, C1 Esterase Inhibitor Subcutaneous (Human), on Facebook!
HAEGARDA is an injectable medicine used to prevent swelling and/or painful attacks in adults and adolescents with hereditary angioedema (HAE). We hope this page serves as a valuable and engaging resource for people impacted by HAE, including patients who are already on HAEGARDA or want to learn more about HAEGARDA, as well as their family and friends. We’re here to provide important information about HAE and how HAEGARDA can help you break free from HAE. We will also offer helpful tips, provide alerts to upcoming events, and deliver inspiring stories from other people living with HAE. Feel free to share the content on this page with your family and friends to keep the conversation going.
We do ask that all users comply with Facebook’s Terms of Use. To review Facebook’s Community Standards, please visit the following webpage: https://www.facebook.com/communitystandards. Please consult CSL Behring’s Privacy Policy (https://www.haegarda.com/privacy-policy) and Terms of Use (https://www.haegarda.com/terms-of-use) to understand the rules applicable to your use of the site. As a friendly reminder, this page is intended for users 18 and over and US audiences only.